skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Hi,

I think the payor mix and reimbursement changes are the largest risk to this company. Assuming much more margin pressure, using very conservative estimates, my DCF model points to a higher value then current share price. Their products and services are essential and I can’t foresee a substitute. Am I missing something? Do you guys see any major long-term trends that could threaten their business model?
I have a long-term outlook (5 years out) and can handle volatility. Would you say the probabilities of a double from today's share price in 5 years is high?

Thanks,
R
Read Answer Asked by Ramin on August 04, 2017
Q: Your portfolio review was helpful and appreciated. Am gradually tweaking our savings re diversification. Presently no healthcare. Am mulling a 3 - 5% (of equity) stake. We can do this in either Cdn or US$. The US healthcare sector is our preference. If we use our Cdn$, it appears you favour ZUH? Can you recommend an equivalent etf if we use our US$? I'm also hoping for your thoughts on whether now even the time to take a position in healthcare (given the current confusion down south) or would we be better off just to add this cash to our SPY or XSP. Thanks for your help.
Read Answer Asked by Bill on July 28, 2017
Q: Greetings 5i,

Enteromedics Inc - NASDAQ. Implanted pacemaker-like device that inhibits the nerve pathway from stomach to brain reducing sensations of hunger thus resulting in weight loss. With implants currently underway in many patients, can a case be made for taking a small Speculative position?

Cheers!
Read Answer Asked by Duane on July 27, 2017
Q: I'm long CRH but I'm trying to consider all the negative outcomes that could take place. We are aware of the proposed code changes that will effect the reimbursement rate to CRH. But I keep hearing that private insurers will likely follow suit and cut back their reimbursement rate. If only the gov rate cut is factored into this big pull back could there possibly not be another big pull back if they cut back as well? I know CRH came out and stated what the hit to earnings would roughly be from GOV cuts but aren't the private insurers the majority of their income. Thanks
Read Answer Asked by Adam on July 27, 2017
Q: Just a follow-up to the information I posted on Sunday: TDSI Action notes report yesterday, revised their target price from the $10 to $5.50 and calling the stock a HOLD. The analyst (only one) states that the 00740 and 00810 codes are being broken into 5 separate codes. "Although the changes include a mixture of rate cuts and increases, we believe the net effect could be an 8.5% reduction in CRH's realized rates."
"The underlying ASSUMPTION is that the proposed rules are implemented as is on January 1 2018".
He also believes the changes will hamper CRH's M&A activity.
Let's hope this analyst ( Lennox Gibbs) has decided to be ultra conservative after being comfortable on Friday.
Clarence
Read Answer Asked by Clarence on July 19, 2017
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!